In previous studies, transcutaneous electrical nerve stimulation (TENS) has been applied to patients with either Alzheimer’s disease (AD) or incipient dementia, resulting in an enhancement in memory and verbal fluency. Moreover, affective behavior was shown to improve. Based on the positive effects of TENS in AD, it was hypothesized that TENS would improve self-efficacy in nondemented elderly with mild cognitive impairment (MCI) who live in a residential home. Four outcome measures, that is, a Dutch translation of the General Self-Efficacy Scale (Algemene Competentie Schaal), the Groninger Activity Restriction Scale, the Philadelphia Geriatric Center Morale Scale, and the Geriatric Depression Scale, were administered. Overall, the results suggest that the experimental group showed a mild improvement in self-efficacy and mood. In contrast, the placebo group showed a considerable reduction in self-efficacy and an increase in depression. Limitations of the present study and suggestions for future research are discussed.
1. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology2001;56(9):1133-1142.
2.
2. Petersen RC, Doody R, Kurz A, et al.Current concepts in mild cognitive impairment. Arch Neurol2001;58(12):1985-1992.
3.
3. Meyer J, Xu G, Thornby J, Chowdhury M, Quach M. Longitudinal analysis of abnormal domains comprising mild cognitive impairment (MCI) during aging. J Neurol Sci2002;201(1-2):19-25.
4.
4. Collie A, Maruff P. The neuropsychology of preclinical Alzheimer’s disease and mild cognitive impairment. Neurosci Biobehav Rev2000;24(3):365-374.
5.
5. Wang QS, Zhou JN. Retrieval and encoding of episodic memory in normal aging and patients with mild cognitive impairment. Brain Res2002;924(1):113-115.
6.
6. Wolf H, Grunwald M, Ecke GM, et al.The prognosis of mild cognitive impairment in the elderly. J Neural Transm Suppl1998;54:31-50.
7.
7. Raz N, Gunning FM, Head D, et al.Selective aging of the human cerebral cortex observed in vivo: differential vulnerability of the prefrontal gray matter. Cereb Cortex1997;7(3):268-282.
8.
8. Bartres-Faz D, Junque C, Lopez-Alomar A, et al.Neuropsychological and genetic differences between age-associated memory impairment and mild cognitive impairment entities. J Am Geriatr Soc2001;49(7):985-990.
9.
9. Huang C, Wahlund LO, Almkvist O, et al.Voxel- and VOI-based analysis of SPECT CBF in relation to clinical and psychological heterogeneity of mild cognitive impairment. Neuroimage2003;19(3):1137-1144.
10.
10. Morris JC. Challenging assumptions about Alzheimer’s disease: mild cognitive impairment and the cholinergic hypothesis. Ann Neurol2002;51(2):143-144.
11.
11. Grimes AL, McCullough LB, Kunik ME, Molinari V, Workman RH Jr.Informed consent and neuroanatomic correlates of intentionality and voluntariness among psychiatric patients. Psychiatr Serv2000;51(12):1561-1567.
12.
12. Cahn-Weiner DA, Boyle PA, Malloy PF. Tests of executive function predict instrumental activities of daily living in community-dwelling older individuals. Appl Neuropsychol2002;9(3):187-191.
13.
13. Grigsby J, Kaye K, Baxter J, Shetterly SM, Hamman RF. Executive cognitive abilities and functional status among community-dwelling older persons in the San Luis Valley Health and Aging Study. J Am Geriatr Soc1998;46(5):590-596.
14.
14. Richardson J, Bedard M, Weaver B. Changes in physical functioning in institutionalized older adults. Disabil Rehabil2001;23(15):683-689.
15.
15. Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev1977;84(2):191-215.
16.
16. Barkley RA. The executive functions and self-regulation: an evolutionary neuropsychological perspective. Neuropsychol Rev2001;11(1):1-29.
17.
17. Davis KD, Taylor SJ, Crawley AP, Wood ML, Mikulis DJ. Functional MRI of pain- and attention-related activations in the human cingulate cortex. J Neurophysiol1997;77(6): 3370-3380.
18.
18. Scherder EJ, Bouma A, Steen AM. Effects of short-term transcutaneous electrical nerve stimulation on memory and affective behaviour in patients with probable Alzheimer’s disease. Behav Brain Res1995;67(2):211-219.
19.
19. Scherder EJ, Bouma A, Steen LM. Effects of “isolated” transcutaneous electrical nerve stimulation on memory and affective behavior in patients with probable Alzheimer’s disease. Biol Psychiatry1998;43(6):417-424.
20.
20. Scherder EJ, Bouma A. Effects of transcutaneous electrical nerve stimulation on memory and behavior in Alzheimer’s disease may be stage-dependent. Biol Psychiatry1999;45(6):743-749.
21.
21. Scherder EJ, Van Someren EJ, Bouma A, Berg M. Effects of transcutaneous electrical nerve stimulation (TENS) on cognition and behaviour in aging. Behav Brain Res2000;111(1-2):223-225.
22.
22. Mancuso CA, Rincon M, McCulloch CE, Charlson ME. Self-efficacy, depressive symptoms, and patients’ expectations predict outcomes in asthma. Med Care2001;39(12):1326-1338.
23.
23. Swaab DF, Dubelaar EJ, Hofman MA, Scherder EJ, Van Someren EJ, Verwer RW. Brain aging and Alzheimer’s disease; use it or lose it. Prog Brain Res2002;138:343-373.
24.
24. Swaab DF. Nuclei of the human hypothalamus. Part 1. In: Aminos MJ, Boller S, Swaab DF, eds. Handbook of clinical neurology. Amsterdam: Elsevier Science; 2003.
25.
25. Swaab DF. Neuropathology of the human hypothalamus and adjacent structures. Part 2. In: Aminos MJ, Boller S, Swaab DF, eds. Handbook of clinical neurology. Amsterdam: Elsevier Science; 2004.
26.
26. Kayama Y, Koyama Y. Brainstem neural mechanisms of sleep and wakefulness. Eur Urol1998;33(Suppl 3):12-15.
27.
27. Van Gaalen M, Kawahara H, Kawahara Y, Westerink BH. The locus coeruleus noradrenergic system in the rat brain studied by dual-probe microdialysis. Brain Res1997;763(1):56-62.
28.
28. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res1975;12(3):189-198.
29.
29. Dufouil C, Clayton D, Brayne C, et al.Population norms for the MMSE in the very old: estimates based on longitudinal data. Mini-Mental State Examination. Neurology2000;55(11):1609-1613.
30.
30. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol1999;56(3):303-308.
31.
31. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology1984;34(7):939-944.
32.
32. Wechsler D. Wechsler Memory Scale-Revised. New York: The Psychological Corporation; 1984.
33.
33. Delis DC, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test. Research edition. New York: The Psychological Corporation Harcourt Brace Jovanovich Inc; 1987.
34.
34. Mulder JL, Dekker R, Dekker PH. Verbale Leer en Geheugen Test. Lisse, the Netherlands: Swets & Zietlinger; 1995.
35.
35. Snijders JTh, Verhage F. Groninger Intelligentie Test. Lisse, the Netherlands: Swets & Zeitlinger; 1983.
36.
36. Reitan RM, Wolfson D. The Halstead-Reitan Neuropsychology Test Battery. Tuscon, AZ: Neuropsychology Press; 1985.
37.
37. Bosscher RJ, Smith JH, Kempen GIJM. Algemene competentieverwachtingen bij ouderen. Nederlands Tijdschrift voor de Psychologie1997;52:239-248.
38.
38. Sherer M, Maddux JE, Mercandante B, Prentice-Dunn S, Jacobs B, Rogers RW. The self-efficacy scale: construction and validation. Psychol Rep1982;51:663-671.
39.
39. Bosscher RJ, Baardman I. Het meten van gepercipeerde competentie bij psychiatrische patienten. Bewegen en Hulpverlening1989;6:312-322.
40.
40. Bosscher RJ, Laurijssen L, Boer Ed.Competentie op latere leeftijd: een exploratieve studie. Bewegen en Hulpverlening1992;9:255-265.
41.
41. Suurmeijer TP, Doeglas DM, Moum T, et al.The Groningen Activity Restriction Scale for measuring disability: its utility in international comparisons. Am J Public Health1994;84(8): 1270-1273.
42.
42. Kempen GIJM, Suurmeijer ThPBM. The development of a hierarchical polychotomous ADL-IADL scale for noninstitutionalized elders. The Gerontologist1990;30:497-502.
43.
43. Kempen GIJM, Doeglas DM, Suurmeijer TPBM. Het meten van problemen met zelfredzaamheid op verzorgend en huishoudelijk gebied met de Groningen Activiteiten Restrictie Schaal (GARS). Een handleiding [Grongingen Activity Restriction Scale]. Groningen, the Netherlands: University of Groningen, Northern Centre for Health Care Research; 1993.
44.
44. Lawton MP. The Philadelphia Geriatric Center Morale Scale: a revision. J Gerontol1975;30(1):85-89.
45.
45. Lawton MP. The dimensions of morale. In: Kent D, Kastenbaum R, Sherwood S, eds. Research, planning and action for the elderly. New York: Behavioral Publications; 1972.
46.
46. Rai GS, Jetten E, Collas D, Hoefnagels W, Froeling P, Bor H. Study to assess quality of life (morale and happiness) in two continuing care facilities—a comparative study in the UK and the Netherlands. Arch Gerontol Geriatr1995;20:249-253.
47.
47. Brink TL, Yesavage JA, Heersema PH, Adey M, Rose TL. Screening tests for geriatric depression. Arch Gen Psychiatry1982;4:53-63.
48.
48. Sheikh JL, Yesavage JA. Geriatric Depression Scale (GDS). Recent evidence of development of a shorter version. Clin Gerontol1986;5:165-173.
49.
49. Yesavage JA, Brink TL, Rose TL, et al.Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res1982;17(1):37-49.
50.
50. Kok RM, Heeren ThJ, van Hemert AM. De Geriatric Depression Scale. Tijdschrift voor Psychiatrie1993;35(6):416-421.
51.
51. Laprise R, Vézina J. Diagnostic performance of the Geriatric Depression Scale and the Beck Depression Inventory with nursing home residents. Can J Aging1998;17(4):401-413.
52.
52. Dudar JD, Whishaw IQ, Szerb JC. Release of acetylcholine from the hippocampus of freely moving rats during sensory stimulation and running. Neuropharmacology1979;18(8-9):673-678.
53.
53. Dutar P, Lamour Y, Jobert A. Activation of identified septohippocampal neurons by noxious peripheral stimulation. Brain Res1985;328(1):15-21.
54.
54. Huan-Ji D, Yan-fang C. Localization of central structures involved in descending inhibitory effect of acupuncture on viscero-somatic reflex discharges. Sci Sin1976;19:137-148.
55.
55. Coffey GH, Mahon MV. Pain: theories and a new approach to treatment. J Natl Med Assoc1982;74(2):147-153.
57. Guieu R, Tardy-Gervet MF, Blin O, Pouget J. Pain relief achieved by transcutaneous electrical nerve stimulation and/or vibratory stimulation in a case of painful legs and moving toes. Pain1990;42(1):43-48.
58.
58. Guieu R, Tardy-Gervet MF, Roll JP. Analgesic effects of vibration and transcutaneous electrical nerve stimulation applied separately and simultaneously to patients with chronic pain. Can J Neurol Sci1991;18(2):113-119.
59.
59. Omura Y. Basic electrical parameters for safe and effective electro-therapeutics [electro-acupuncture, TES, TENMS (or TEMS), TENS and electro-magnetic field stimulation with or without drug field] for pain, neuromuscular skeletal problems, and circulatory disturbances. Acupunct Electrother Res1987;12(3-4):201-225.
60.
60. Jorum E, Shyu BC. Analgesia by low-frequency nerve stimulation mediated by low-threshold afferents in rats. Pain1988;32(3):357-366.
61.
61. Jones SL, Gebhart GF. Spinal pathways mediating tonic, coeruleospinal, and raphe-spinal descending inhibition in the rat. J Neurophysiol1987;58(1):138-159.
62.
62. Mokha SS, McMillan JA, Iggo A. Descending control of spinal nociceptive transmission. Actions produced on spinal multi-receptive neurones from the nuclei locus coeruleus (LC) and raphe magnus (NRM). Exp Brain Res1985;58(2): 213-226.
63.
63. Soric R, Devlin M. Transcutaneous electrical nerve stimulation. Practical aspects and applications. Postgrad Med1985;78(4): 101-107.
64.
64. Wolf SL. Perspectives on central nervous system responsiveness to transcutaneous electrical nerve stimulation. Phys Ther1978;58(12):1443-1449.
65.
65. Duranti R, Pantaleo T, Bellini F. Increase in muscular pain threshold following low frequency-high intensity peripheral conditioning stimulation in humans. Brain Res1988;452(1-2):66-72.
66.
66. Eriksson MB, Sjolund BH, Nielzen S. Long term results of peripheral conditioning stimulation as an analgesic measure in chronic pain. Pain1979;6(3):335-347.
67.
67. Scherder EJ, Luijpen MW, van Dijk KR. Activation of the dorsal raphe nucleus and locus coeruleus by transcutaneous electrical nerve stimulation in Alzheimer’s disease: a reconsideration of stimulation-parameters derived from animal studies. Chin J Physiol2003;46(4):143-150.
68.
68. Norusis MJ. Statistical Packages for the Social Sciences, SPSS/PC+. New York: McGraw-Hill; 1988.
69.
69. Lopez OL, Jagust WJ, Dulberg C, et al.Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2. Arch Neurol2003;60(10):1394-1399.
70.
70. Van Dyck CH. Neuroimaging in Alzheimer’s disease: relevance for treatment. Curr Psychiatry Rep2001;3(1):13-19.
71.
71. Sjogren M, Hesse C, Basun H, et al.Tacrine and rate of progression in Alzheimer’s disease—relation to ApoE allele genotype. J Neural Transm2001;108(4):451-458.
72.
72. Yaffe K, Haan M, Byers A, Tangen C, Kuller L. Estrogenuse, APOE, and cognitive decline: evidence of gene-environment interaction. Neurology2000;54(10):1949-1954.
73.
73. Benedetti F, Amanzio M, Casadio C, Oliaro A, Maggi G. Blockade of nocebo hyperalgesia by the cholecystokinin antagonist proglumide. Pain1997;71(2):135-140.
74.
74. Kennedy WP. The nocebo reaction. Med Exp Int J Exp Med1961;95:203-205.
75.
75. Hahn RA. A sociocultural model of illness and healing. In: White L, Tursky B, Schwartz GE, eds. Placebo: theory, research, and mechanisms. New York: Guilford; 1985:167-195.
76.
76. Hahn RA. The nocebo phenomenon: scope and foundations. In: Harrington A, ed. The placebo effect: an interdisciplinary exploration. Cambridge, MA: Harvard University Press; 1997.
77.
77. Ader R. Conditioned responses in pharmacotherapy research. Psychol Med1993;23(2):297-299.
78.
78. Kirsch I. Specifying nonspecifics: psychological mechanisms of placebo effects. In: Harrington A, ed. The placebo effect. London: Harvard University Press; 1997.
